ResearcherUniversity of VeronaActive in the last 2 years
Raffaella Pacchiana
Matched on OpenAlex author ID A5029880735. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 28
2018: 2 papers · 2019: none · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 3 papers
Papers 10
- First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models. Co-author DOI 10.1021/acs.jmedchem.6c00235↗
- Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal adenocarcinoma cells. First author DOI 10.1111/febs.70223↗
- Metabolic plasticity underlies ferroptosis resistance driven by mutant p53 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12943-026-02746-y↗
- Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1038/s41419-025-08082-1↗
- Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells. Co-author DOI 10.1016/j.ejmech.2023.115286↗
- Tumor Suppressor Role of Wild-Type P53-Dependent Secretome and Its Proteomic Identification in PDAC. Co-author DOI 10.3390/biom12020305↗
- 3-Bromo-Isoxazoline Derivatives Inhibit GAPDH Enzyme in PDAC Cells Triggering Autophagy and Apoptotic Cell Death. Co-author DOI 10.3390/cancers14133153↗
- Extracellular Matrix Composition Modulates the Responsiveness of Differentiated and Stem Pancreatic Cancer Cells to Lipophilic Derivate of Gemcitabine. Co-author DOI 10.3390/ijms22010029↗
- Trichostatin A alters cytoskeleton and energy metabolism of pancreatic adenocarcinoma cells: An in depth proteomic study. Co-author DOI 10.1002/jcb.26436↗
- Mutant p53 prevents GAPDH nuclear translocation in pancreatic cancer cells favoring glycolysis and 2-deoxyglucose sensitivity. First author DOI 10.1016/j.bbamcr.2018.10.005↗
Closest collaborators
The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Massimo Donadelli · 10 shared papers, 2018–2026 · strength 1.67
- Paper Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal ad… DOI 10.1111/febs.70223↗
- Paper Metabolic plasticity underlies ferroptosis resistance driven by mutant p53 in pancreatic ductal adenocarcinoma. DOI 10.1186/s12943-026-02746-y↗
- Paper First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models. DOI 10.1021/acs.jmedchem.6c00235↗
- Adriana Celesia · 4 shared papers, 2025–2026 · strength 0.95
- Paper Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal ad… DOI 10.1111/febs.70223↗
- Paper Metabolic plasticity underlies ferroptosis resistance driven by mutant p53 in pancreatic ductal adenocarcinoma. DOI 10.1186/s12943-026-02746-y↗
- Paper First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models. DOI 10.1021/acs.jmedchem.6c00235↗
- Alessandra Fiore · 4 shared papers, 2025–2026 · strength 0.95
- Paper Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal ad… DOI 10.1111/febs.70223↗
- Paper Metabolic plasticity underlies ferroptosis resistance driven by mutant p53 in pancreatic ductal adenocarcinoma. DOI 10.1186/s12943-026-02746-y↗
- Paper First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models. DOI 10.1021/acs.jmedchem.6c00235↗
- Federica Danzi · 3 shared papers, 2025–2026 · strength 0.72
- Paper Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal ad… DOI 10.1111/febs.70223↗
- Paper Metabolic plasticity underlies ferroptosis resistance driven by mutant p53 in pancreatic ductal adenocarcinoma. DOI 10.1186/s12943-026-02746-y↗
- Paper Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells. DOI 10.1038/s41419-025-08082-1↗
- Daniela Cecconi · 4 shared papers, 2018–2026 · strength 0.69
- Paper Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal ad… DOI 10.1111/febs.70223↗
- Paper Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells. DOI 10.1038/s41419-025-08082-1↗
- Paper Tumor Suppressor Role of Wild-Type P53-Dependent Secretome and Its Proteomic Identification in PDAC. DOI 10.3390/biom12020305↗
- Paola Conti · 4 shared papers, 2018–2026 · strength 0.63
- Paper First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models. DOI 10.1021/acs.jmedchem.6c00235↗
- Paper Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity ag… DOI 10.1016/j.ejmech.2023.115286↗
- Paper 3-Bromo-Isoxazoline Derivatives Inhibit GAPDH Enzyme in PDAC Cells Triggering Autophagy and Apoptotic Cell Death. DOI 10.3390/cancers14133153↗
- Maria Poles · 2 shared papers, 2026 · strength 0.53
- Paper Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal ad… DOI 10.1111/febs.70223↗
- Paper Metabolic plasticity underlies ferroptosis resistance driven by mutant p53 in pancreatic ductal adenocarcinoma. DOI 10.1186/s12943-026-02746-y↗
- Claudio Luchini · 2 shared papers, 2025–2026 · strength 0.44
- Paper Metabolic plasticity underlies ferroptosis resistance driven by mutant p53 in pancreatic ductal adenocarcinoma. DOI 10.1186/s12943-026-02746-y↗
- Paper Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells. DOI 10.1038/s41419-025-08082-1↗
- Giovanna Butera · 3 shared papers, 2018–2025 · strength 0.41
- Paper Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells. DOI 10.1038/s41419-025-08082-1↗
- Paper Tumor Suppressor Role of Wild-Type P53-Dependent Secretome and Its Proteomic Identification in PDAC. DOI 10.3390/biom12020305↗
- Paper Mutant p53 prevents GAPDH nuclear translocation in pancreatic cancer cells favoring glycolysis and 2-deoxyglucose sensi… DOI 10.1016/j.bbamcr.2018.10.005↗
- Chiara Borsari · 2 shared papers, 2023–2026 · strength 0.41
- Jessica Brandi · 3 shared papers, 2018–2025 · strength 0.41
- Paper Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells. DOI 10.1038/s41419-025-08082-1↗
- Paper Tumor Suppressor Role of Wild-Type P53-Dependent Secretome and Its Proteomic Identification in PDAC. DOI 10.3390/biom12020305↗
- Paper Trichostatin A alters cytoskeleton and energy metabolism of pancreatic adenocarcinoma cells: An in depth proteomic stud… DOI 10.1002/jcb.26436↗
- Elisa Dalla Pozza · 3 shared papers, 2018–2022 · strength 0.31
- Paper 3-Bromo-Isoxazoline Derivatives Inhibit GAPDH Enzyme in PDAC Cells Triggering Autophagy and Apoptotic Cell Death. DOI 10.3390/cancers14133153↗
- Paper Extracellular Matrix Composition Modulates the Responsiveness of Differentiated and Stem Pancreatic Cancer Cells to Lip… DOI 10.3390/ijms22010029↗
- Paper Trichostatin A alters cytoskeleton and energy metabolism of pancreatic adenocarcinoma cells: An in depth proteomic stud… DOI 10.1002/jcb.26436↗
- Stefania Forciniti · 2 shared papers, 2020–2022 · strength 0.23
- Paper 3-Bromo-Isoxazoline Derivatives Inhibit GAPDH Enzyme in PDAC Cells Triggering Autophagy and Apoptotic Cell Death. DOI 10.3390/cancers14133153↗
- Paper Extracellular Matrix Composition Modulates the Responsiveness of Differentiated and Stem Pancreatic Cancer Cells to Lip… DOI 10.3390/ijms22010029↗
- Ilaria Dando · 2 shared papers, 2020–2022 · strength 0.23
- Paper 3-Bromo-Isoxazoline Derivatives Inhibit GAPDH Enzyme in PDAC Cells Triggering Autophagy and Apoptotic Cell Death. DOI 10.3390/cancers14133153↗
- Paper Extracellular Matrix Composition Modulates the Responsiveness of Differentiated and Stem Pancreatic Cancer Cells to Lip… DOI 10.3390/ijms22010029↗
- Emílio Marengo · 2 shared papers, 2018–2022 · strength 0.22
- Antonio Pea · 1 shared paper, 2025 · strength 0.19
- Costas Andreas Lyssiotis · 1 shared paper, 2025 · strength 0.19
- Aldo Scarpa · 1 shared paper, 2025 · strength 0.19
- Roberto Salvia · 1 shared paper, 2025 · strength 0.19
- Andrea Galbiati · 1 shared paper, 2023 · strength 0.18
- Maria Raffaella Greco · 1 shared paper, 2020 · strength 0.09
- Tiago M. A. Carvalho · 1 shared paper, 2020 · strength 0.09
- Stephan J. Reshkin · 1 shared paper, 2020 · strength 0.09
- Marta Palmieri · 1 shared paper, 2020 · strength 0.09
- Rosa Angela Cardone · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.